Lancet Neurology

The Lancet is a weekly peer-reviewed general medical journal. It is one of the world s best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing. In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). The Lancet also has several speciality journals all bearing the parent title: The Lancet Neurology (neurology), The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious diseases), all of which publish original research and reviews. These three

Publisher
Elsevier
History
1823–present
Impact factor
33.633 (2010)
Some content from Wikipedia, licensed under CC BY-SA

Increased mobility thanks to robotic rehab

After a stroke, patients often struggle with persistent paresis. ETH researchers examined whether robot-assisted therapy can help stroke patients. This form of therapy proved successful particularly with ...

Jan 16, 2014
popularity 5 / 5 (1) | comments 0

Gel reduced daily tremors in Parkinson's disease

(Medical Xpress)—An experimental treatment for Parkinson's disease reduced by nearly two hours on average the period each day when medication failed to control patients' slowness and shaking, according to results from a ...

Jan 06, 2014
popularity 5 / 5 (1) | comments 0 | with audio podcast

Study puts Huntington's disease trials on TRACK

(Medical Xpress)—A three-year multinational study has tracked and detailed the progression of Huntington's disease (HD), predicting clinical decline in people carrying the HD gene more than 10 years before ...

May 21, 2013
popularity not rated yet | comments 0